{"uid":"cap_bdf4IeB28D3X7axUQdz6x","slug":"bnm-data-shop-fda-untitled-letters-5936aa98","name":"BNM Data Shop – FDA Untitled Letters","description":"Official public data as JSON. Unpaid paid routes return HTTP 402.","url":"https://ticks.bnm.farm/untitled-letters","method":"GET","headers":{},"bodySchema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"type":{"type":"string","const":"http"},"method":{"enum":["GET","HEAD","DELETE"],"type":"string"},"headers":{"type":"object","additionalProperties":{"type":"string"}},"queryParams":{"type":"object","additionalProperties":{"type":"string"}}},"additionalProperties":false},"output":{"type":"object","properties":{"type":{"type":"string"},"schema":{"type":"object"},"example":{"type":"object"}}}}},"responseSchema":{"type":"json","example":{"ok":true,"asOf":"2026-04-28","cards":[{"id":"bayer-healthcare-pharmaceuticals-inc-192241","body":"The Office of Prescription Drug Promotion (OPDP) of the U.S. Food and Drug Administration (FDA) has reviewed the promotional communications…","date":"2026-04-28","firm":"Bayer HealthCare Pharmaceuticals, Inc.","said":"FDA has determined that the video and TV ad are false or misleading.","cites":["FD&C Act"],"office":"OPDP","product":"NUBEQA® (darolutamide) tablets, for oral use","sourceUrl":"https://www.fda.gov/media/192241/download"}],"source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/issuance-untitled-letters","status":"ok","product":"fda-untitled-letter-bodies","records":[{"id":"bayer-healthcare-pharmaceuticals-inc-192241","url":"https://www.fda.gov/media/192241/download","date":"2026-04-28","firm":"Bayer HealthCare Pharmaceuticals, Inc.","type":"untitled-letter"}],"fetchedAt":"2026-08-19T22:20:31.840Z","recordCount":1}},"example":null,"exampleRequest":null,"tags":["x402"],"displayCostAmount":"0.05","displayCostAsset":"USDC","priceDynamic":false,"priceHint":null,"priceStatus":"priced","priceSource":"probe","requiresHandshake":false,"reviewCount":0,"rating":{"score":"0.00","successRate":"0.00","reviews":0,"stars":null,"state":"unrated"},"availabilityStatus":"unknown","priceObserved":null,"sessionDeposit":null,"pricing":{"kind":"static","summary":"$0.05/call","primary":{"kind":"static","protocol":"x402","network":"base","amountUsd":"0.05","per":"call","confidence":"exact"},"accepted":[{"kind":"static","protocol":"x402","network":"base","amountUsd":"0.05","per":"call","confidence":"exact"}]},"paymentMethods":[{"uid":"pm_9gPR88KuhRDORjGCjLyXr","protocol":"x402","methodType":"crypto","chain":"base","mode":"charge","costAmount":"0.05","costPer":"request","priority":0,"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","unit":"request","depositMicros":null,"planRef":null}],"brandName":null,"brandSlug":null,"brandBaseUrl":null,"brandDocsUrl":null,"whatItDoes":"Returns a structured JSON list of FDA untitled letters (promotional compliance enforcement actions) with firm names, products, cited regulations, and letter body text.","exampleAgentPrompt":"Can you pull the latest FDA untitled letters from BNM Data Shop so I can see which pharma companies recently received enforcement actions for misleading drug promotions?","exampleUseCases":[{"title":"Pharma compliance monitoring dashboard","prompt":"Fetch me the latest FDA untitled letters so I can update our compliance dashboard with any new enforcement actions against drug manufacturers."},{"title":"Due diligence on a pharma firm","prompt":"I'm researching Bayer HealthCare — can you check whether they've received any FDA untitled letters for false or misleading promotional activities?"},{"title":"Regulatory newsletter content","prompt":"Pull today's FDA untitled letters so I can summarize the newest promotional compliance actions for our weekly pharma regulatory newsletter."}],"resultDescription":"Returns a JSON object with an 'ok' status, an 'asOf' date, a list of 'cards' (each containing the letter body, date, firm, product, cited regulations, and FDA source URL), a 'records' array of metadata-only entries, a record count, and a fetchedAt timestamp. Data is sourced directly from FDA's public compliance enforcement pages.","failureModes":["HTTP 402 Payment Required if x402 payment is not included — must pay $0.05 USDC per call","Empty records array if no new letters have been issued recently","Network timeout if FDA source is temporarily unavailable","Stale fetchedAt timestamp if upstream FDA data has not been refreshed"],"whenToPreferThis":"Choose this endpoint when you need structured, machine-readable FDA untitled letter data without scraping FDA's website yourself. It is ideal for compliance monitoring, regulatory due diligence, or enriching pharma datasets. Prefer it over raw FDA web scraping when you want clean JSON with parsed fields (firm, product, cited law, letter body). It complements warning-letter endpoints if you specifically need the softer 'untitled letter' category of FDA enforcement.","instructions":null,"reviewSummary":null,"reviewSummaryHighlights":null,"reviewSummaryConcerns":null,"reviewSummaryGeneratedAt":null,"activationCount":0,"lastUsedAt":null,"lastSuccessfullyRanAt":null,"lastHealthCheckAt":"2026-09-15T06:41:47.988Z","isFirstParty":false}